| Thomas D Nagle, MD | |
|
2400 32nd Ave S, Fargo, ND 58103-5800 | |
| (701) 234-8770 | |
| (701) 234-8779 |
| Full Name | Thomas D Nagle |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 2400 32nd Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255359832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 4178 (North Dakota) | Primary |
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
IntelGenx Corp. ("IntelGenx") today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a formal Notice of Allowance for a key patent application protecting IntelGenx's CPI-300, a novel, high strength formulation of bupropion hydrochloride ("HCl"), the active ingredient in Wellbutrin XL(R).
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
Bristol-Myers Squibb Company and Isis Pharmaceuticals have announced a collaboration to discover, develop and commercialize novel antisense drugs targeting proprotein convertase subtilisin kexin 9 (PCSK9) for the prevention and treatment of cardiovascular disease.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased coronary tissue and guide therapeutic interventions, today announced that its next-generation LipiScan IVUS Coronary Imaging System will be featured at EuroPCR 2010, an international educational conference focused on introducing the latest techniques, updates and breakthrough science to the interventional cardiology community.
› Verified 6 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
IntelGenx Corp. ("IntelGenx") today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a formal Notice of Allowance for a key patent application protecting IntelGenx's CPI-300, a novel, high strength formulation of bupropion hydrochloride ("HCl"), the active ingredient in Wellbutrin XL(R).
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
Bristol-Myers Squibb Company and Isis Pharmaceuticals have announced a collaboration to discover, develop and commercialize novel antisense drugs targeting proprotein convertase subtilisin kexin 9 (PCSK9) for the prevention and treatment of cardiovascular disease.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased coronary tissue and guide therapeutic interventions, today announced that its next-generation LipiScan IVUS Coronary Imaging System will be featured at EuroPCR 2010, an international educational conference focused on introducing the latest techniques, updates and breakthrough science to the interventional cardiology community.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas D Nagle, MD 2400 32nd Ave S, Fargo, ND 58103-5800 Ph: (701) 234-8770 | Thomas D Nagle, MD 2400 32nd Ave S, Fargo, ND 58103-5800 Ph: (701) 234-8770 |
News Archive
IntelGenx Corp. ("IntelGenx") today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a formal Notice of Allowance for a key patent application protecting IntelGenx's CPI-300, a novel, high strength formulation of bupropion hydrochloride ("HCl"), the active ingredient in Wellbutrin XL(R).
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
Bristol-Myers Squibb Company and Isis Pharmaceuticals have announced a collaboration to discover, develop and commercialize novel antisense drugs targeting proprotein convertase subtilisin kexin 9 (PCSK9) for the prevention and treatment of cardiovascular disease.
InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased coronary tissue and guide therapeutic interventions, today announced that its next-generation LipiScan IVUS Coronary Imaging System will be featured at EuroPCR 2010, an international educational conference focused on introducing the latest techniques, updates and breakthrough science to the interventional cardiology community.
› Verified 6 days ago
Jason M Erpelding, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-417-6000 | |
Dr. Charles Richard Hartz, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-239-3700 Fax: 701-237-2633 | |
Dr. Anthony N Brown, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-280-4140 | |
David M Beard, MD, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1720 University Dr S, Fargo, ND 58103 Phone: 701-280-4101 | |
Parth Ashok Vyas, M.S Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-2345 | |
Brian Sauer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2301 25th St S, Fargo, ND 58103 Phone: 701-234-2000 | |
Dr. Derek Anthony Mclister, D.P.M Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 |